These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 2679026

  • 1. Role of biologically modified low-density lipoprotein in atherosclerosis.
    Carew TE.
    Am J Cardiol; 1989 Oct 03; 64(13):18G-22G. PubMed ID: 2679026
    [Abstract] [Full Text] [Related]

  • 2. In vivo inhibition of foam cell development by probucol in Watanabe rabbits.
    Steinberg D, Parthasarathy S, Carew TE.
    Am J Cardiol; 1988 Jul 25; 62(3):6B-12B. PubMed ID: 3394654
    [Abstract] [Full Text] [Related]

  • 3. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Carew TE, Schwenke DC, Steinberg D.
    Proc Natl Acad Sci U S A; 1987 Nov 25; 84(21):7725-9. PubMed ID: 3478721
    [Abstract] [Full Text] [Related]

  • 4. Probucol does not affect lipoprotein metabolism in macrophages of Watanabe heritable hyperlipidemic rabbits.
    Nagano Y, Kita T, Yokode M, Ishii K, Kume N, Otani H, Arai H, Kawai C.
    Arteriosclerosis; 1989 Nov 25; 9(4):453-61. PubMed ID: 2751475
    [Abstract] [Full Text] [Related]

  • 5. The role of oxidized low density lipoprotein in the pathogenesis of atherosclerosis.
    Kita T, Ishii K, Yokode M, Kume N, Nagano Y, Arai H, Kawai C.
    Eur Heart J; 1990 Aug 25; 11 Suppl E():122-7. PubMed ID: 2226520
    [Abstract] [Full Text] [Related]

  • 6. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Kleinveld HA, Demacker PN, Stalenhoef AF.
    Arterioscler Thromb; 1994 Aug 25; 14(8):1386-91. PubMed ID: 8049202
    [Abstract] [Full Text] [Related]

  • 7. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
    Lauridsen ST, Mortensen A.
    Atherosclerosis; 1999 Jan 25; 142(1):169-78. PubMed ID: 9920518
    [Abstract] [Full Text] [Related]

  • 8. Prevention of atherosclerotic progression in Watanabe rabbits by probucol.
    Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Narumiya S, Kawai C.
    Am J Cardiol; 1988 Jul 25; 62(3):13B-19B. PubMed ID: 3394648
    [Abstract] [Full Text] [Related]

  • 9. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.
    O'Brien K, Nagano Y, Gown A, Kita T, Chait A.
    Arterioscler Thromb; 1991 Jul 25; 11(3):751-9. PubMed ID: 2029510
    [Abstract] [Full Text] [Related]

  • 10. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
    Kita T, Yokode M, Ishii K, Kume N, Nagano Y, Arai H, Otani H, Ueda Y, Hara S.
    Clin Exp Pharmacol Physiol Suppl; 1992 Jul 25; 20():37-42. PubMed ID: 1446408
    [Abstract] [Full Text] [Related]

  • 11. Probucol inhibits oxidative modification of low density lipoprotein.
    Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D.
    J Clin Invest; 1986 Feb 25; 77(2):641-4. PubMed ID: 3944273
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.
    Fruebis J, Steinberg D, Dresel HA, Carew TE.
    J Clin Invest; 1994 Jul 25; 94(1):392-8. PubMed ID: 8040279
    [Abstract] [Full Text] [Related]

  • 13. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy.
    O'Leary VJ, Tilling L, Fleetwood G, Stone D, Darley-Usmar V.
    Atherosclerosis; 1996 Jan 26; 119(2):169-79. PubMed ID: 8808494
    [Abstract] [Full Text] [Related]

  • 14. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.
    Witting P, Pettersson K, Ostlund-Lindqvist AM, Westerlund C, Wâgberg M, Stocker R.
    J Clin Invest; 1999 Jul 26; 104(2):213-20. PubMed ID: 10411551
    [Abstract] [Full Text] [Related]

  • 15. Probucol as an antioxidant and antiatherogenic drug.
    Kuzuya M, Kuzuya F.
    Free Radic Biol Med; 1993 Jan 26; 14(1):67-77. PubMed ID: 8454225
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants.
    Fruebis J, Bird DA, Pattison J, Palinski W.
    J Lipid Res; 1997 Dec 26; 38(12):2455-64. PubMed ID: 9458269
    [Abstract] [Full Text] [Related]

  • 18. S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
    Breugnot C, Privat S, Guillonneau C, Regnier G, Bouzom F, Vilaine JP, Lenaers A.
    J Pharmacol Exp Ther; 1994 May 26; 269(2):515-20. PubMed ID: 8182520
    [Abstract] [Full Text] [Related]

  • 19. A modern view of atherogenesis.
    Schwartz CJ, Valente AJ, Sprague EA.
    Am J Cardiol; 1993 Feb 25; 71(6):9B-14B. PubMed ID: 8434561
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.